Target intelligence / Profile preview

Oxidative stress pathways via enterolignan metabolites

Molecular classification
Metabolic pathway, Signaling pathway
01

Overview

Oxidative stress pathways via enterolignan metabolites refer to the complex biochemical interactions involving gut microbiota-derived compounds, specifically enterolactone and enterodiol, which are formed from dietary plant lignans (Adlercreutz, 2007). These metabolites act as potent antioxidants and weak phytoestrogens, playing a crucial role in maintaining cellular redox balance by activating the Nuclear factor erythroid 2-related factor 2 (Nrf2) pathway (Peterson et al., 2010). Upon activation, Nrf2 translocates to the nucleus and binds to the Antioxidant Response Element (ARE), triggering the expression of protective enzymes like superoxide dismutase and glutathione peroxidase (Wang, 2002). Additionally, enterolignans modulate inflammatory responses by inhibiting the NF-kappaB signaling cascade, thereby reducing oxidative damage associated with chronic inflammation (During et al., 2012). Their biological relevance is primarily linked to the prevention of hormone-dependent cancers and cardiovascular diseases, where they mitigate the harmful effects of reactive oxygen species (Pellegrini et al., 2010). Because this entry describes a multi-step biological process and a class of metabolites rather than a specific protein or receptor, it is classified as a pathway rather than a discrete therapeutic target.

Other names
Enterolignan-mediated antioxidant signalingLignan metabolite pathwaysEnterolactone and enterodiol redox modulation
02

Mechanism of action

Activation of the Nrf2/ARE antioxidant signaling pathway and competitive modulation of estrogen receptors alpha and beta.

03

Biological functions

Antioxidant responseEstrogen receptor modulationAnti-inflammatory responseRedox homeostasis
04

Disease associations

CancerCardiovascular diseaseMetabolic syndromeNeurodegenerative disease
05

Safety considerations

Phytoestrogenic interference with endocrine therapiesHigh inter-individual variability due to gut microbiome compositionPotential for biphasic effects on hormone-sensitive tissues
06

Interacting drugs

Enterolactone

2 more in the full profile.

07

Biomarkers

Serum enterolactoneUrinary enterolactoneMalondialdehyde8-hydroxy-2-deoxyguanosine

Beyond the preview

Go deeper on Oxidative stress pathways via enterolignan metabolites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidative stress pathways via enterolignan metabolites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call